{"title":"SLE患者的心智抗体和中枢神经系统受累:鉴别诊断","authors":"H. Prüss","doi":"10.1136/lupus-2019-la.18","DOIUrl":null,"url":null,"abstract":"1. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019;78(6):736–45. 2. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73(6):958–67. 3. Md Yusof MY, Psarras A, El-Sherbiny YM, et al. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Ann Rheum Dis 2018;77(10):1432–39. 4. El-Sherbiny YM, Md Yusof MY, Psarras A, et al. B cell tetherin: a flow-cytometric cell-specific assay for response to Type-I interferon predicts clinical features and flares in SLE. bioRxiv 2019:554352.","PeriodicalId":280862,"journal":{"name":"Hot Topic Lecture","volume":"83 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"01 Mind antibodies and CNS involvement in SLE: differential diagnoses\",\"authors\":\"H. Prüss\",\"doi\":\"10.1136/lupus-2019-la.18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019;78(6):736–45. 2. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73(6):958–67. 3. Md Yusof MY, Psarras A, El-Sherbiny YM, et al. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Ann Rheum Dis 2018;77(10):1432–39. 4. El-Sherbiny YM, Md Yusof MY, Psarras A, et al. B cell tetherin: a flow-cytometric cell-specific assay for response to Type-I interferon predicts clinical features and flares in SLE. bioRxiv 2019:554352.\",\"PeriodicalId\":280862,\"journal\":{\"name\":\"Hot Topic Lecture\",\"volume\":\"83 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hot Topic Lecture\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/lupus-2019-la.18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hot Topic Lecture","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2019-la.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
1. Fanouriakis A, Kostopoulou M, Alunno A等。2019更新EULAR关于系统性红斑狼疮管理的建议。中国生物医学工程学报，2019;38(6):736 - 745。2. 范浩文，莫斯卡，波提斯，等。系统性红斑狼疮的靶向治疗:来自国际工作组的建议。中国生物医学工程学报，2014;33(6):958 - 967。3.Md Yusof MY, Psarras A, El-Sherbiny YM，等。自身免疫性结缔组织疾病在高危人群中的预测:一种新的干扰素状态双评分系统的预后价值中华医学杂志，2018,37(10):1432 - 1439。4. El-Sherbiny YM, Md Yusof MY, Psarras A，等。B细胞栓素:对i型干扰素反应的流式细胞术细胞特异性测定预测SLE的临床特征和耀斑。bioRxiv 2019:554352。
01 Mind antibodies and CNS involvement in SLE: differential diagnoses
1. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019;78(6):736–45. 2. van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73(6):958–67. 3. Md Yusof MY, Psarras A, El-Sherbiny YM, et al. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Ann Rheum Dis 2018;77(10):1432–39. 4. El-Sherbiny YM, Md Yusof MY, Psarras A, et al. B cell tetherin: a flow-cytometric cell-specific assay for response to Type-I interferon predicts clinical features and flares in SLE. bioRxiv 2019:554352.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
